PlainPharmaWatch

CMS Open Payments · Program Year 2024

Gamida Cell Inc.

Gamida Cell Inc. reported $372,439.78 in payments to 26 physicians and teaching hospitals across 48 transactions.

See the rankings → How this is sourced
$372.4K
Total payments
48
Transactions
26
Recipients
#848
of 1,925 companies

Gamida Cell Inc. reported $372,439.78 in payments to 26 physicians and teaching hospitals in CMS Open Payments Program Year 2024 - ranking #848 of 1,925 reporting manufacturers (0.0% of all US industry payments), averaging $14.3K per recipient across 2 payment categories. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.

Compiled from official public sources by the editorial team.

The verdict

Gamida Cell Inc. pairs above-median payment volume with a broadly spread payment pattern across many recipients.

#848
of 1,925 companies
0.0%
of all US industry payments
0.2%
paid to its single top recipient
2
payment categories

How Gamida Cell Inc. ranks nationally

Where this company's total reported payments fall within the full national distribution of all 1,925 companies in CMS Open Payments, not just its nearest peers.

Gamida Cell Inc.'s total vs. every reporting company

CMS Open Payments, Program Year 2024

$372,440 Top 44% higher than 56% of 1,925 reporting companies

$9–$28: 3 reporting companies (0%). Below this entry. $28–$87: 10 reporting companies (1%). Below this entry. $87–$270: 20 reporting companies (1%). Below this entry. $270–$838: 41 reporting companies (2%). Below this entry. $838–$2,603: 76 reporting companies (4%). Below this entry. $2,603–$8,084: 114 reporting companies (6%). Below this entry. $8,084–$25,112: 167 reporting companies (9%). Below this entry. $25,112–$78,003: 249 reporting companies (13%). Below this entry. $78,003–$242,294: 295 reporting companies (15%). Below this entry. $242,294–$752,621: 270 reporting companies (14%). This entry sits in this band. $752,621–$2,337,813: 263 reporting companies (14%). Above this entry. $2,337,813–$7,261,783: 200 reporting companies (10%). Above this entry. $7,261,783–$22,556,757: 133 reporting companies (7%). Above this entry. $22,556,757–$70,066,439: 45 reporting companies (2%). Above this entry. $70,066,439–$217,642,369: 26 reporting companies (1%). Above this entry. $217,642,369–$676,046,922: 13 reporting companies (1%). Above this entry. This company $9 $676,046,922 every reporting company, bucketed by value

Each bar is a progressively wider band; taller bars hold more reporting companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Open Payments · 2024

What the Data Shows for Gamida Cell Inc.

$372,439.78: that is what Gamida Cell Inc. reported in payments to 26 physicians and teaching hospitals during Program Year 2024, spread across 48 transactions ($7.8K per transaction, $14.3K per recipient). The company sits at rank #848 of 1,925, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.

Of the 2 general-payment categories charted below, "Consulting Fee" is the largest at $30.4K across 11 transactions, 8.2% of the company's reported total (see our methodology for how research and ownership payments are reported separately).

General Payment Breakdown by Type

"Consulting Fee" leads Gamida Cell Inc.'s 2-category general-payment breakdown at $30.4K, 8.2% of the reported total.

How Gamida Cell Inc. divides its payments

Ranked by total dollars reported per category

1. Consulting Fee$30.4K2. Food and Beverage$1.1K
Payment Type Amount Transactions
Consulting Fee $30.4K 11
Food and Beverage $1.1K 15

Recipient Concentration in General Payments

The five largest recipient relationships account for $19,672.79 (62.4%) of $31,545.94 in this company's General Payments records across 22 recipients. This is a CMS Open Payments Program Year 2024 General Payments view only: it excludes research and ownership/investment records, so it is not the all-category company total above.

Largest General-Payment relationships for Gamida Cell Inc.

The five named recipients with the highest reported General Payments from this company

Leland Metheny$6.0KKoen Van Besien$5.0KFilippo Milano$3.5KGeorge Yaghmour$2.5KPatrick Stiff$2.5K
  1. 1

    Leland Metheny

    $6,050.00 across 2 reported transactions

  2. 2

    Koen Van Besien

    $5,000.00 across 1 reported transactions

  3. 3

    Filippo Milano

    $3,522.79 across 2 reported transactions

  4. 4

    George Yaghmour

    $2,550.00 across 1 reported transactions

  5. 5

    Patrick Stiff

    $2,550.00 across 1 reported transactions

Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.

Payment Size Analysis

Average transaction size: $7.8K. Average per recipient: $14.3K.

Total Amount

$372,439.78

Avg per Transaction

$7.8K

Avg per Recipient

$14.3K

Payment Transparency Context

What is the Sunshine Act?

The Physician Payments Sunshine Act (part of the Affordable Care Act) requires pharmaceutical and medical device manufacturers to report payments and transfers of value to physicians and teaching hospitals. These payments can include consulting fees, research grants, speaker fees, food and beverages, travel, royalties, and other forms of compensation.

Industry Total (2024)

$13.9B

across 1,925 companies

Gamida Cell Inc. Share

0.0%

#848 by total payments

Companies with Similar Payment Volumes

Pharmaceutical companies with payment totals similar to Gamida Cell Inc.

Curiteva, Inc.

$373.8K 285 recipients

American Orthodontics Corporation

$374.7K 7,064 recipients

Altus Partners. LLC

$374.7K 240 recipients

American Regent

$375.1K 109 recipients

Trice Medical, Inc.

$369.8K 663 recipients

Maillefer Instruments Holding Sarl

$369.3K 26 recipients

Frequently Asked Questions

How much did Gamida Cell Inc. pay to physicians and hospitals in 2024? ▾
Gamida Cell Inc. made $372,439.78 in payments to physicians and hospitals in Program Year 2024, across 48 individual transactions. This represents 0.0% of all industry payments reported to CMS Open Payments.
How many physicians received payments from Gamida Cell Inc.? ▾
Averaging $14.3K per recipient, Gamida Cell Inc.'s 2024 payments reached 26 physicians and teaching hospitals.
What types of payments did Gamida Cell Inc. make? ▾
2 categories of general payment make up Gamida Cell Inc.'s reported activity, including consulting, meals, travel, and similar types. The largest general-payment category was "Consulting Fee" at $30.4K, representing 8.2% of the company's reported total.
How does Gamida Cell Inc. rank among pharmaceutical companies? ▾
By total payment amount, Gamida Cell Inc. sits at #848 of 1,925 companies in the CMS Open Payments database for 2024.
What is the average payment size from Gamida Cell Inc.? ▾
The average transaction from Gamida Cell Inc. was $7.8K in 2024. The company made 48 total transactions to 26 recipients.
Where does the payment data for Gamida Cell Inc. come from? ▾
This data comes from the CMS Open Payments program (Sunshine Act), which requires pharmaceutical and medical device companies to report payments and transfers of value to physicians and teaching hospitals. The data covers Program Year 2024.

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch Editorial
Disclaimer

This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

View saved (companies)
Download Gamida Cell Inc.'s data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-25.